Equity Analysis

Company News

    Sunrest Lifescience Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    91669
    INE0PLZ01012
    33.0471663
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    SUNREST
    111.32
    25.32
    EPS(TTM)
    Face Value()
    Div & Yield %:
    0.53
    10
    0
     
Dwarikesh Sugar Industries Ltd - Dwarikesh Sugar Industries Limited - Other General Purpose
Feb 04,2025
Dwarikesh Sugar Industries Limitedo. DSIL/2024-2025/249 & letter no. DSIL/2024-2025/262 dated February 04, 2025. In view of the above, the company has now filed rectified Limited Review Report along with unaudited financial results for quarter and nine months ended December 31, 2024 (Q3) on February 04, 2025. Please note that, change in Limited Review Report is in respect of word audited used inadvertently instead of reviewed under point no 1. Besides the said rectification there are no other revisions/changes in Limited Review report or unaudited Financial Results for Q3. The above information is also available on the website of the Company https://www.dwarikesh.com/results.html You are kindly requested acknowledge the receipt and take the same on record.